Folic acid in general medicine and dermatology

Folic acid is a vitamin B essential for the integrity and function of DNA. Relative deficiency of folic acid may occur in conditions such as pregnancy and hyperproliferative or chronic inflammatory disorders. Folic acid supplementation has been proven to be beneficial in the prevention of neural tube defects and in limiting methotrexate side effects, and may reduce the risk of colorectal cancer. Folate is a critical vitamin in determining plasma homocysteine levels, which in turn is a major risk factor for cardiovascular diseases. The results of large clinical trials with dietary supplementation of folic acid, vitamin B12 and vitamin B6 have shown that this homocysteine‐lowering therapy is effective in the secondary prevention of non‐fatal strokes, but had no effect in the prevention of fatal cardiovascular diseases. Hyperhomocysteinemia has also been reported in age‐related neurological conditions with cognitive impairment (e.g. dementia), and psychiatric disorders such as depression. Elevated homocysteine levels are frequent in patients with chronic immune‐mediated disorders including rheumatoid arthritis, systemic lupus erythematosus, chronic plaque psoriasis and psoriatic arthritis, which have in common a tendency to an accelerated atherosclerosis leading to increased deaths from cardiovascular events. Folic acid supplementation appears as a reasonable therapeutic option in patients affected by chronic inflammatory skin diseases, such as moderate to severe psoriasis; in particular, those with concomitant hyperhomocysteinemia, low plasma folate and additional cardiovascular risk factors.

[1]  M. Fava,et al.  Nutrition and depression: the role of folate. , 2009, Nutrition reviews.

[2]  P. Gisondi,et al.  Plasma homocysteine and folate levels in patients with chronic plaque psoriasis , 2006, The British journal of dermatology.

[3]  J. Mann,et al.  A controlled trial of homocysteine lowering and cognitive performance. , 2006, The New England journal of medicine.

[4]  A. Ilchyshyn,et al.  Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double‐blind, placebo‐controlled trial , 2006, The British journal of dermatology.

[5]  A. Mangoni.  Folic acid, inflammation, and atherosclerosis: false hopes or the need for better trials? , 2006, Clinica chimica acta; international journal of clinical chemistry.

[6]  R. Zimmermann,et al.  Folic acid: a public-health challenge , 2006, The Lancet.

[7]  E. Rimm,et al.  Folate supplementation and cardiovascular disease , 2006, The Lancet.

[8]  Per Magne Ueland,et al.  Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.

[9]  F. Meiss,et al.  Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences. , 2006, European journal of dermatology : EJD.

[10]  E. Ferrannini,et al.  Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects , 2006, International Journal of Obesity.

[11]  Michael Hinckley,et al.  Impact of obesity and smoking on psoriasis presentation and management. , 2005, Archives of dermatology.

[12]  B. Lebowitz,et al.  The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. , 2005, The international journal of neuropsychopharmacology.

[13]  S. Ebrahim,et al.  Folate supplementation and cardiovascular disease , 2005, The Lancet.

[14]  B. Strober,et al.  Folate supplementation during methotrexate therapy for patients with psoriasis. , 2005, Journal of the American Academy of Dermatology.

[15]  M. Landray,et al.  Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. , 2005, The American journal of clinical nutrition.

[16]  W. Willett,et al.  Folate Intake and Risk of Breast Cancer Characterized by Hormone Receptor Status , 2005, Cancer Epidemiology Biomarkers & Prevention.

[17]  L. Naldi,et al.  Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. , 2005, The Journal of investigative dermatology.

[18]  I. Mcdowell,et al.  Homocysteine and endothelial function in human studies. , 2005, Seminars in vascular medicine.

[19]  L. Bailey,et al.  Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. , 2005, The American journal of clinical nutrition.

[20]  G. Davey Smith,et al.  Taking folate in pregnancy and risk of maternal breast cancer , 2005, BMJ : British Medical Journal.

[21]  Mark Lucock,et al.  Folic acid — vitamin and panacea or genetic time bomb? , 2005, Nature Reviews Genetics.

[22]  M. Boffa,et al.  Methotrexate for psoriasis: current European practice. A postal survey , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[23]  S. Feldman,et al.  The comorbid state of psoriasis patients in a university dermatology practice , 2005, The Journal of dermatological treatment.

[24]  U. Hoffmann,et al.  Mild hyperhomocysteinemia: risk factor or just risk predictor for cardiovascular diseases? , 2004, VASA. Zeitschrift fur Gefasskrankheiten.

[25]  H. Suryapranata,et al.  Folate therapy and in-stent restenosis after coronary stenting. , 2004, The New England journal of medicine.

[26]  G. Goodwin,et al.  Folate for Depressive Disorders: Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2004, Journal of psychopharmacology.

[27]  J. Severens,et al.  Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis. , 2004, The Journal of rheumatology.

[28]  J. Erickson,et al.  Vitamin supplements and the risk for congenital anomalies other than neural tube defects , 2004, American journal of medical genetics. Part C, Seminars in medical genetics.

[29]  K. Svärdsudd,et al.  Reported symptoms and clinical findings in relation to serum cobalamin, folate, methylmalonic acid and total homocysteine among elderly Swedes: a population‐based study , 2003, Journal of internal medicine.

[30]  A. Gottlieb,et al.  Connections between psoriasis and Crohn's disease. , 2003, Journal of the American Academy of Dermatology.

[31]  A. Alver,et al.  Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[32]  F. Granath,et al.  Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients , 2003, European Journal of Epidemiology.

[33]  Hiroyuki Suzuki,et al.  Sequence-specific DNA damage induced by ultraviolet A-irradiated folic acid via its photolysis product. , 2003, Archives of biochemistry and biophysics.

[34]  H. McNulty,et al.  The effect of different cooking methods on folate retention in various foods that are amongst the major contributors to folate intake in the UK diet. , 2002, The British journal of nutrition.

[35]  Per Magne Ueland,et al.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. , 2002, JAMA.

[36]  G. Girolomoni,et al.  Livedoid vasculopathy and skin ulcers in patients with inherited thrombophilia. , 2002, European journal of dermatology : EJD.

[37]  M. Law,et al.  Quantifying the effect of folic acid , 2001, The Lancet.

[38]  J. Lüthy,et al.  Folate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence. , 2001, Swiss medical weekly.

[39]  R. Harbour,et al.  A new system for grading recommendations in evidence based guidelines , 2001, BMJ : British Medical Journal.

[40]  P. Jacques,et al.  Power Shortage: Clinical Trials Testing the Homocysteine Hypothesis against a Background of Folic AcidFortified Cereal Grain Flour , 2001, Annals of Internal Medicine.

[41]  B. Dijkmans,et al.  Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. , 2001, Arthritis and rheumatism.

[42]  M. Lucock,et al.  Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. , 2000, Molecular genetics and metabolism.

[43]  F. D'armiento,et al.  Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. , 2000, The Journal of rheumatology.

[44]  Y. Kim,et al.  Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. , 1999, Nutrition reviews.

[45]  I. Rosenberg,et al.  Serum Total Homocysteine Concentrations in the Third National Health and Nutrition Examination Survey (19911994): Population Reference Ranges and Contribution of Vitamin Status to High Serum Concentrations , 1999, Annals of Internal Medicine.

[46]  G A Colditz,et al.  A prospective study of folate intake and the risk of breast cancer. , 1999, JAMA.

[47]  H. Blom,et al.  Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials , 1998, BMJ.

[48]  J. Manson,et al.  Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. , 1998, JAMA.

[49]  S. Vollset,et al.  Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. , 1998, The American journal of clinical nutrition.

[50]  L. Juhlin,et al.  Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. , 1997, Acta dermato-venereologica.

[51]  E. Rimm,et al.  A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. , 1996, Cancer research.

[52]  A. Wahba-Yahav.  Disease concomitance in psoriasis. , 1996, Journal of the American Academy of Dermatology.

[53]  N R Campbell,et al.  How safe are folic acid supplements? , 1996, Archives of internal medicine.

[54]  M. De Vos,et al.  Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study. , 1995, The Journal of rheumatology.

[55]  L. Montes,et al.  Folic acid and vitamin B12 in vitiligo: a nutritional approach. , 1992, Cutis.

[56]  D. M. Hoffman,et al.  Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. , 1991, Annals of the rheumatic diseases.

[57]  J. Culebras,et al.  [Folates in human nutrition, Different clinical situations in which folate deficiencies exist]. , 1991, Nutricion hospitalaria.

[58]  S. Young,et al.  Folic acid and psychopathology , 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[59]  C. Halsted.  The intestinal absorption of dietary folates in health and disease. , 1989, Journal of the American College of Nutrition.

[60]  R. Russell,et al.  Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid. , 1988, The Journal of laboratory and clinical medicine.

[61]  J. Pincus,et al.  Transport characteristics of folates in cerebrospinal fluid; a study utilizing doubly labeled 5-methyltetrahydrofolate and 5-formyltetrahydrofolate. , 1971, The Journal of clinical investigation.

[62]  L. Fry,et al.  THE MECHANISM OF FOLATE DEFICIENCY IN PSORIASIS , 1971, The British journal of dermatology.

[63]  M. Righetti.  Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients , 2007, Clinical chemistry and laboratory medicine.

[64]  Richard Gordon,et al.  A hypothesis linking low folate intake to neural tube defects due to failure of post-translation methylations of the cytoskeleton. , 2006, The International journal of developmental biology.

[65]  A. A. Liakishev.  [Homocysteine lowering with folic acid and B vitamins in vascular disease]. , 2006, Kardiologiia.

[66]  F. Trivin,et al.  Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. , 2006, Clinical chemistry.

[67]  J. Callen,et al.  Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. , 2006, Archives of dermatology.

[68]  K. Hamulýak,et al.  Recurrent leg ulcers in a young man with hyperhomocysteinemia, factor V Leiden and impaired fibrinolysis. , 2002, Acta dermato-venereologica.

[69]  L Juhlin,et al.  Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. , 2002, Acta dermato-venereologica.

[70]  I. Rebelo,et al.  Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[71]  W. Willett,et al.  Diet and coronary heart disease: findings from the Nurses' Health Study and Health Professionals' Follow-up Study. , 2001, The journal of nutrition, health & aging.

[72]  R. Matthews,et al.  The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia , 1999, Nature Structural Biology.

[73]  H. Hoffman,et al.  Serum concentrations of zinc, folate, vitamins A and E, and proteins, and their relationships to pregnancy outcome. , 1997, Acta obstetricia et gynecologica Scandinavica. Supplement.

[74]  P. Frosst,et al.  Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. , 1996, American journal of human genetics.

[75]  N. Geller,et al.  Systemic absorption of a leucovorin mouth wash: a pharmacologic study. , 1987, Cancer investigation.

[76]  D. Hild.  Folate losses from the skin in exfoliative dermatitis. , 1969, Archives of internal medicine.